keyword
https://read.qxmd.com/read/38632094/the-interaction-of-pu-1-and-cmyb-in-zebrafish-neutrophil-development
#1
JOURNAL ARTICLE
Hong Jia-Xin, Xu Song'en, Zhang Wen-Qing, Liu Wei
Granulopoiesis is a highly ordered and precisely regulated process in which hematopoietic-related transcription factors play crucial roles. These transcription factors form complex regulatory networks through interactions with their co-factors or with each other, and anomalies in these networks can lead to the onset of leukemia. While the structures and functions of dozens of transcription factors involved in this process have been extensively studied, research on the regulatory relationships between these factors remains relatively limited...
April 20, 2024: Yi Chuan, Hereditas
https://read.qxmd.com/read/38594640/assessment-of-the-fret-based-teen-sensor-to-monitor-erk-activation-changes-preceding-morphological-defects-in-a-rasopathy-zebrafish-model-and-phenotypic-rescue-by-mek-inhibitor
#2
JOURNAL ARTICLE
Giulia Fasano, Stefania Petrini, Valeria Bonavolontà, Graziamaria Paradisi, Catia Pedalino, Marco Tartaglia, Antonella Lauri
BACKGROUND: RASopathies are genetic syndromes affecting development and having variable cancer predisposition. These disorders are clinically related and are caused by germline mutations affecting key players and regulators of the RAS-MAPK signaling pathway generally leading to an upregulated ERK activity. Gain-of-function (GOF) mutations in PTPN11, encoding SHP2, a cytosolic protein tyrosine phosphatase positively controlling RAS function, underlie approximately 50% of Noonan syndromes (NS), the most common RASopathy...
April 9, 2024: Molecular Medicine
https://read.qxmd.com/read/38385270/targeting-tnf-il-17-mapk-pathway-in-h-e2a-pbx1-leukemia-effects-of-oul35-kj-pyr-9-and-cid44216842
#3
JOURNAL ARTICLE
Haiping Luo, Qiqi Li, Jiaxin Hong, Zhibin Huang, Wenhui Deng, Kunpeng Wei, Siyu Lu, Hailong Wang, Wenqing Zhang, Wei Liu
t(1;19)(q23;p13) is one of the most common translocation genes in childhood acute lymphoblastic leukemia (ALL) and is also present in acute myeloid leukemia (AML) and mixed-phenotype acute leukemia (MPAL). This translocation results in the formation of the oncogenic E2A-PBX1 fusion protein, which contains a trans-activating domain from E2A and a DNA-binding homologous domain from PBX1. Despite its clear oncogenic potential, the pathogenesis of E2A-PBX1 fusion protein is not fully understood (especially in leukemias other than ALL), and effective targeted clinical therapies have not been developed...
February 22, 2024: Haematologica
https://read.qxmd.com/read/38368795/cytotoxicity-of-dioncophylline-a-and-related-naphthylisoquinolines-in-leukemia-cells-mediated-by-nf-%C3%AE%C2%BAb-inhibition-angiogenesis-suppression-g2-m-cell-cycle-arrest-and-autophagy-induction
#4
JOURNAL ARTICLE
Rümeysa Yücer, Shaimaa Fayez, Doris Feineis, Sabine M Klauck, Letian Shan, Gerhard Bringmann, Thomas Efferth, Mona Dawood
BACKGROUND: Inhibition of NF-κB activity represents a strategy to treat acute myeloid leukemia, one of the most lethal leukemia types. Naphthylisoquinolines (NIQs) are cytotoxic alkaloids from lianas of the families Ancistrocladaceae and Dioncophyllaceae, which are indigenous to tropical rainforests. PURPOSE: Uncovering therapeutic possibilities and underlying molecular mechanisms of dioncophylline A and its derivatives towards NF-κB related cellular processes...
December 8, 2023: Phytomedicine
https://read.qxmd.com/read/38326409/znf687-recruits-brd4-smrt-complex-to-regulate-gfi1aa-during-neutrophil-development
#5
JOURNAL ARTICLE
Lin Yan, Shuiyi Tan, Haihong Wang, Hao Yuan, Xiaohui Liu, Yi Chen, Hugues de Thé, Jun Zhu, Jun Zhou
Neutrophils are key component of the innate immune system in vertebrates. Diverse transcription factors and cofactors act in a well-coordinated manner to ensure proper neutrophil development. Dysregulation of the transcriptional program triggering neutrophil differentiation is associated with various human hematologic disorders such as neutropenia, neutrophilia, and leukemia. In the current study we show the zinc finger protein Znf687 is a lineage-preferential transcription factor, whose deficiency leads to an impaired neutrophil development in zebrafish...
February 7, 2024: Leukemia
https://read.qxmd.com/read/38185059/the-rac1-inhibitor-ehop-016-attenuates-aml-cell-migration-and-enhances-the-efficacy-of-daunorubicin-in-molm-13-transplanted-zebrafish-larvae
#6
JOURNAL ARTICLE
Anette Lodvir Hemsing, Jan-Lukas Førde, Håkon Reikvam, Lars Herfindal
Ras-related C3 botulinum toxin substrate 1 (Rac1) is a GTPase implicated in cell migration and homing of hematopoietic cells to the hematopoietic niche, and is commonly overexpressed in acute myeloid leukemia (AML). This can lead to quiescence of leukemic blasts in the niche and reduced response to therapy. We investigated the Rac1 inhibitor EHop-016 on AML by assessing its effects on MOLM-13 cells in vitro and in zebrafish larvae, regarding cell motility and therapeutic potential in combination with daunorubicin (DNR)...
January 5, 2024: Translational Oncology
https://read.qxmd.com/read/38184222/exploring-the-in-vivo-anti-cancer-potential-of-neosetophomone-b-in-leukemic-cells-using-a-zebrafish-xenograft-model
#7
JOURNAL ARTICLE
Shilpa Kuttikrishnan, Maram Hasan, Kirti S Prabhu, Tamam El-Elimat, Nicholas H Oberlies, Cedric J Pearce, Feras Q Alali, Aamir Ahmad, Ehsan P Daryakenari, Ajaz A Bhat, Huseyin C Yalcin, Shahab Uddin
Neosetophomone B (NSP-B) is a unique meroterpenoid fungal secondary metabolite that has previously demonstrated promising anti-cancer properties against various cancer cell lines in vitro. However, its in vivo anti-cancer potential remaines unexplored. To fill this gap in our knowledge, we tested NSP-B's in vivo anti-cancer activity using a zebrafish model, an organism that has gained significant traction in biomedical research due to its genetic similarities with humans and its transparent nature, allowing real-time tumor growth observation...
January 4, 2024: Experimental Cell Research
https://read.qxmd.com/read/38136366/generation-of-a-zebrafish-knock-in-model-recapitulating-childhood-etv6-runx1-positive-b-cell-precursor-acute-lymphoblastic-leukemia
#8
JOURNAL ARTICLE
Veronika Zapilko, Sanni Moisio, Mataleena Parikka, Merja Heinäniemi, Olli Lohi
Approximately 25% of children with B-cell precursor acute lymphoblastic leukemia (pB-ALL) harbor the t(12;21)(p13;q22) translocation, leading to the ETV6::RUNX1 (E::R) fusion gene. This translocation occurs in utero, but the disease is much less common than the prevalence of the fusion in newborns, suggesting that secondary mutations are required for overt leukemia. The role of these secondary mutations remains unclear and may contribute to treatment resistance and disease recurrence. We developed a zebrafish model for E::R leukemia using CRISPR/Cas9 to introduce the human RUNX1 gene into zebrafish etv6 intron 5, resulting in E::R fusion gene expression controlled by the endogenous etv6 promoter...
December 13, 2023: Cancers
https://read.qxmd.com/read/38117861/constitutively-active-camkii-drives-b-lineage-acute-lymphoblastic-leukemia-lymphoma-in-tp53-mutant-zebrafish
#9
JOURNAL ARTICLE
Sarah C Rothschild, Guanhua Lai, Robert M Tombes, Wilson K Clements
Acute lymphoblastic leukemia/lymphoma (ALL) is the most common pediatric cancer and is a malignancy of T or B lineage lymphoblasts. Dysregulation of intracellular Ca2+ levels has been observed in patients with ALL, leading to improper activation of downstream signaling. Here we describe a new zebrafish model of B ALL, generated by expressing human constitutively active CaMKII (CA-CaMKII) in tp53 mutant lymphocytes. In this model, B cell hyperplasia in the kidney marrow and spleen progresses to overt leukemia/lymphoma, with only 29% of zebrafish surviving the first year of life...
December 20, 2023: PLoS Genetics
https://read.qxmd.com/read/38104416/zebrafish-drug-screening-identifies-erlotinib-as-an-inhibitor-of-wnt-%C3%AE-catenin-signaling-and-self-renewal-in-t-cell-acute-lymphoblastic-leukemia
#10
JOURNAL ARTICLE
Majd A Al-Hamaly, Anna H Cox, Meghan G Haney, Wen Zhang, Emma C Arvin, Shilpa Sampathi, Mary Wimsett, Chunming Liu, Jessica S Blackburn
The Wnt/β-catenin pathway's significance in cancer initiation, progression, and stem cell biology underscores its therapeutic potential. However, the clinical application of Wnt inhibitors remains limited due to challenges posed by off-target effects and complex cross-talk of Wnt signaling with other pathways. In this study, we leveraged a zebrafish model to perform a robust and rapid drug screening of 773 FDA-approved compounds to identify Wnt/β-catenin inhibitors with minimal toxicity. Utilizing zebrafish expressing a Wnt reporter, we identified several drugs that suppressed Wnt signaling without compromising zebrafish development...
December 15, 2023: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38058200/casz1-upregulates-pi3k-akt-mtor-signaling-and-promotes-t-cell-acute-lymphoblastic-leukemia
#11
JOURNAL ARTICLE
Bruno A Cardoso, Mafalda Duque, Ana Gírio, Rita Fragoso, Mariana L Oliveira, James R Allen, Leila R Martins, Nádia C Correia, André Bortolini Silveira, Alexandra Veloso, Shunsuke Kimura, Lisa Demoen, Filip Matthijssens, Sima Jeha, Cheng Cheng, Ching-Hon Pui, Ana R Grosso, João L Neto, Sérgio F De Almeida, Pieter Van Vlieberghe, Charles G Mullighan, J Andres Yunes, David M Langenau, Françoise Pflumio, João T Barata
CASZ1 is a conserved transcription factor involved in neural development, blood vessel assembly and heart morphogenesis. CASZ1 has been implicated in cancer, either suppressing or promoting tumor development depending on the tissue. However, the impact of CASZ1 on hematological tumors remains unknown. Here, we show that the T-cell oncogenic transcription factor TAL1 is a direct positive regulator of CASZ1, that T-cell acute lymphoblastic leukemia (T-ALL) samples at diagnosis overexpress CASZ1b isoform, and that CASZ1b expression in patient samples correlates with PI3KAKT- mTOR signaling pathway activation...
December 7, 2023: Haematologica
https://read.qxmd.com/read/38000356/preclinical-characterization-of-danatinib-as-a-novel-flt3-inhibitor-with-excellent-efficacy-against-resistant-acute-myeloid-leukemia
#12
JOURNAL ARTICLE
Shan-Liang Sun, Jia-Zhen Wu, Jing-Jing Wang, Hai Zhou, Chen-Qian Zhang, Zhen-Jiang Tong, Yi-Bo Wang, Jiu-Kai Sha, Qing-Xin Wang, Jia-Chuan Liu, Xin-Rui Zheng, Qing-Qing Li, Meng-Yuan Zhang, Jin Yang, Tian-Hua Wei, Zi-Xuan Wang, Yan-Cheng Yu, Ning Ding, Xue-Jiao Leng, Xin Xue, He-Min Li, Wei-Chen Dai, Xiao-Ying Yin, Ye Yang, Jin-Ao Duan, Nian-Guang Li, Zhi-Hao Shi
The therapeutic benefits of available FLT3 inhibitors for AML are limited by drug resistance, which is related to mutations, as well toxicity caused by off-target effects. In this study, we introduce a new small molecule FLT3 inhibitor called danatinib, which was designed to overcome the limitations of currently approved agents. Danatinib demonstrated greater potency and selectivity, resulting in cytotoxic activity specific to FLT3-ITD and/or FLT3-TKD mutated models. It also showed a superior kinome inhibition profile compared to several currently approved FLT3 inhibitors...
November 23, 2023: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/37892120/chemical-composition-in-vitro-antitumor-effect-and-toxicity-in-zebrafish-of-the-essential-oil-from-conyza-bonariensis-l-cronquist-asteraceae
#13
JOURNAL ARTICLE
Rafael Carlos Ferreira, Yuri Mangueira do Nascimento, Paulo Bruno de Araújo Loureiro, Rafael Xavier Martins, Maria Eduarda de Souza Maia, Davi Felipe Farias, Josean Fechine Tavares, Juan Carlos Ramos Gonçalves, Marcelo Sobral da Silva, Marianna Vieira Sobral
The essential oil from Conyza bonariensis (Asteraceae) aerial parts (CBEO) was extracted by hydrodistillation in a Clevenger-type apparatus and was characterized by gas chromatography-mass spectrometry. The antitumor potential was evaluated against human tumor cell lines (melanoma, cervical, colorectal, and leukemias), as well as non-tumor keratinocyte lines using the MTT assay. The effect of CBEO on the production of Reactive Oxygen Species (ROS) was evaluated by DCFH-DA assay, and a protection assay using the antioxidant N-acetyl-L-cysteine (NAC) was also performed...
September 24, 2023: Biomolecules
https://read.qxmd.com/read/37860248/-opuntia-ficus-indica-l-mill-anticancer-properties-and-phytochemicals-current-trends-and-future-perspectives
#14
REVIEW
Jiao Wang, Neeraj Rani, Seema Jakhar, Rakesh Redhu, Sanjiv Kumar, Sachin Kumar, Sanjeev Kumar, Bhagwati Devi, Jesus Simal-Gandara, Bairong Shen, Rajeev K Singla
Cancer is a leading cause of mortality worldwide, and conventional cancer therapies such as chemotherapy and radiotherapy often result in undesirable and adverse effects. Natural products have emerged as a promising alternative for cancer treatment, with comparatively fewer side effects reported. Opuntia ficus-indica (L.) Mill., a member of the Cactaceae family, contains a diverse array of phytochemicals, including flavonoids, polyphenols, betalains, and tannins, which have been shown to exhibit potent anticancer properties...
2023: Frontiers in Plant Science
https://read.qxmd.com/read/37855330/cabozantinib-in-neuroendocrine-tumors-tackling-drug-activity-and-resistance-mechanisms
#15
JOURNAL ARTICLE
Chiara Alessandra Cella, Riccardo Cazzoli, Nicola Fazio, Giuseppina De Petro, Germano Gaudenzi, Silvia Carra, Mauro Romanenghi, Francesca Spada, Ilaria Grossi, Isabella Pallavicini, Saverio Minucci, Giovanni Vitale
Neuroendocrine tumors (NETs) are highly vascularized malignancies in which angiogenesis may entail cell proliferation and survival. Among the emerging compounds with antivascular properties, cabozantinib (CAB) appeared promising. We analyzed the antitumor activity of CAB against NETs utilizing in vitro and in vivo models. For cell cultures, we used BON-1, NCI-H727 and NCI-H720 cell lines. Cell viability was assessed by manual count coupled with quantification of cell death, performed through fluorescence-activated cell sorting analysis as propidium iodide exclusion assay...
December 1, 2023: Endocrine-related Cancer
https://read.qxmd.com/read/37809044/a-novel-fluorescent-dye-selectively-images-and-kills-cancer-stem-cells-by-targeting-mitochondria-evidence-from-a-cell-line%C3%A2-based-zebrafish-xenograft-model
#16
JOURNAL ARTICLE
Tao Ren, Meng-Zhe Yang, Wei-Ming Zhang, Liu-Jie Qin, Shou-Chang Zhou, Nan-Nan Cheng, Yuan-Jiao Huang, Jing Sun, Ning Xu, Hua-Bing Sun, Bei-Bei Zhang
Numerous agents such as near-infrared dyes that are characterized by specialized cancer imaging and cytotoxicity effects have key roles in cancer diagnosis and therapy via molecularly targeting special biological tissues, organelles and processes. In the present study, a novel fluorescent compound was demonstrated to inhibit cancer cell proliferation in a zebrafish model with slight in vivo toxicity. Further studies demonstrated selective staining of cancer cells and even putative cancer stem cells via accumulation of the dye in the mitochondria of cancer cells, compared with normal cells...
November 2023: Oncology Letters
https://read.qxmd.com/read/37777166/pinostrobin-modulates-foxo3-expression-nuclear-localization-and-exerts-antileukemic-effects-in-aml-cells-and-zebrafish-xenografts
#17
JOURNAL ARTICLE
Pei-Yi Chen, Ching-Yen Lin, Chia-Ling Wu, Pei Ying Keak, Je-Wen Liou, Wan-Yun Gao, Liang-In Lin, Jui-Hung Yen
Acute myeloid leukemia (AML) is a disease characterized by abnormal cell proliferation in the bone marrow and is the most common quickly progressive leukemia in adults. Pinostrobin, a flavonoid phytochemical, has been reported to exhibit antioxidant, anti-inflammatory, and anticancer properties. In this study, we aimed to investigate the antileukemic effects of pinostrobin and its molecular mechanisms in human AML cells. Our study found that pinostrobin (0-80 μM) significantly reduced the viability of human AML cells, with the pronounced cytotoxic effects observed in MV4-11 > MOLM-13 > HL-60 > U-937 > THP-1 cells...
September 28, 2023: Chemico-biological Interactions
https://read.qxmd.com/read/37713272/cabozantinib-in-neuroendocrine-tumours-tackling-drug-activity-and-resistance-mechanisms
#18
JOURNAL ARTICLE
Chiara Alessandra Cella, Riccardo Cazzoli, Nicola Fazio, Giuseppina De Petro, Germano Gaudenzi, Silvia Carra, Mauro Romanenghi, Francesca Spada, Ilaria Grossi, Isabella Pallavicini, Saverio Minucci, Giovanni Vitale
Neuroendocrine tumours (NETs) are highly vascularized malignancies in which angiogenesis may entail cell proliferation and survival. Among the emerging compounds with anti-vascular properties, cabozantinib (CAB) appeared promising. We analyzed the anti-tumor activity of CAB against NETs utilizing in vitro and in vivo models. For cell cultures we used BON-1, NCI-H727 and NCI-H720 cell lines. Cell viability was assessed by manual count coupled with quantification of cell death, performed through FACS analysis as propidium iodide exclusion assay...
September 1, 2023: Endocrine-related Cancer
https://read.qxmd.com/read/37693603/zebrafish-drug-screening-identifies-erlotinib-as-an-inhibitor-of-wnt-%C3%AE-catenin-signaling-and-self-renewal-in-t-cell-acute-lymphoblastic-leukemia
#19
Majd A Al-Hamaly, Anna H Cox, Meghan G Haney, Wen Zhang, Emma C Arvin, Shilpa Sampathi, Mary Wimsett, Chunming Liu, Jessica S Blackburn
UNLABELLED: The Wnt/β-catenin pathway's significance in cancer initiation, progression, and stem cell biology underscores its therapeutic potential, yet clinical application of Wnt inhibitors remains limited due to challenges posed by off-target effects and complex crosstalk with other pathways. In this study, we leveraged the zebrafish model to perform a robust and rapid drug screening of 773 FDA-approved compounds to identify Wnt/β-catenin inhibitors with minimal toxicity...
August 28, 2023: bioRxiv
https://read.qxmd.com/read/37627164/in-silico-in-vitro-and-in-vivo-investigations-on-adapalene-as-repurposed-third-generation-retinoid-against-multiple-myeloma-and-leukemia
#20
JOURNAL ARTICLE
Joelle C Boulos, Manik Chatterjee, Letian Shan, Thomas Efferth
The majority of hematopoietic cancers in adults are incurable and exhibit unpredictable remitting-relapsing patterns in response to various therapies. The proto-oncogene c-MYC has been associated with tumorigenesis, especially in hematological neoplasms. Therefore, targeting c-MYC is crucial to find effective, novel treatments for blood malignancies. To date, there are no clinically approved c-MYC inhibitors. In this study, we virtually screened 1578 Food and Drug Administration (FDA)-approved drugs from the ZINC15 database against c-MYC...
August 16, 2023: Cancers
keyword
keyword
95794
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.